Access to OMI-DB for research purposes can be granted upon application. Applications are made via a web form and considered by an internal subcommittee made up of members of the OPTIMAM2 steering committee.
All access will be subject to a sharing agreement created in collaboration with CRT (Cancer Research Technology). Applications will be subject to scientific critique and external peer review if deemed proportionate and where the necessary expertise is not available within the subgroup.
Read more about the process of applying for access.